nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.142	0.2	CbGbCtD
Flurazepam—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.142	0.2	CbGbCtD
Flurazepam—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.108	0.152	CbGbCtD
Flurazepam—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0799	0.112	CbGbCtD
Flurazepam—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0633	0.0891	CbGbCtD
Flurazepam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0376	0.0529	CbGbCtD
Flurazepam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0254	0.0357	CbGbCtD
Flurazepam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0242	0.0341	CbGbCtD
Flurazepam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0216	0.0304	CbGbCtD
Flurazepam—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0211	0.0297	CbGbCtD
Flurazepam—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.02	0.0281	CbGbCtD
Flurazepam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0127	0.0178	CbGbCtD
Flurazepam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.012	0.0168	CbGbCtD
Flurazepam—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.00542	0.0291	CcSEcCtD
Flurazepam—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.00389	0.0209	CcSEcCtD
Flurazepam—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.00386	0.0207	CcSEcCtD
Flurazepam—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.0149	CcSEcCtD
Flurazepam—Coma—Aminophylline—chronic obstructive pulmonary disease	0.00243	0.013	CcSEcCtD
Flurazepam—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.00238	0.0127	CcSEcCtD
Flurazepam—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.00216	0.0116	CcSEcCtD
Flurazepam—Thinking abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.0112	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.00199	0.0107	CcSEcCtD
Flurazepam—Withdrawal syndrome—Prednisone—chronic obstructive pulmonary disease	0.0019	0.0102	CcSEcCtD
Flurazepam—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00184	0.00987	CcSEcCtD
Flurazepam—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00926	CcSEcCtD
Flurazepam—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00171	0.00917	CcSEcCtD
Flurazepam—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00916	CcSEcCtD
Flurazepam—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00171	0.00915	CcSEcCtD
Flurazepam—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00169	0.00907	CcSEcCtD
Flurazepam—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00893	CcSEcCtD
Flurazepam—Mental disability—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00889	CcSEcCtD
Flurazepam—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.0088	CcSEcCtD
Flurazepam—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00161	0.00862	CcSEcCtD
Flurazepam—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00154	0.00825	CcSEcCtD
Flurazepam—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00148	0.00792	CcSEcCtD
Flurazepam—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00736	CcSEcCtD
Flurazepam—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00709	CcSEcCtD
Flurazepam—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00699	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.00695	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00694	CcSEcCtD
Flurazepam—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00671	CcSEcCtD
Flurazepam—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.00664	CcSEcCtD
Flurazepam—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00124	0.00663	CcSEcCtD
Flurazepam—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.00652	CcSEcCtD
Flurazepam—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00628	CcSEcCtD
Flurazepam—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.00623	CcSEcCtD
Flurazepam—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.00611	CcSEcCtD
Flurazepam—Amodiaquine—CYP1A1—chronic obstructive pulmonary disease	0.00114	0.173	CrCbGaD
Flurazepam—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00605	CcSEcCtD
Flurazepam—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00594	CcSEcCtD
Flurazepam—Chloroquine—TNF—chronic obstructive pulmonary disease	0.00108	0.164	CrCbGaD
Flurazepam—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00573	CcSEcCtD
Flurazepam—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.00572	CcSEcCtD
Flurazepam—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00554	CcSEcCtD
Flurazepam—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.0055	CcSEcCtD
Flurazepam—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00549	CcSEcCtD
Flurazepam—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00547	CcSEcCtD
Flurazepam—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000989	0.00531	CcSEcCtD
Flurazepam—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000985	0.00528	CcSEcCtD
Flurazepam—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000982	0.00527	CcSEcCtD
Flurazepam—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000972	0.00522	CcSEcCtD
Flurazepam—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000968	0.00519	CcSEcCtD
Flurazepam—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000963	0.00516	CcSEcCtD
Flurazepam—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000948	0.00508	CcSEcCtD
Flurazepam—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000941	0.00505	CcSEcCtD
Flurazepam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00094	0.00504	CcSEcCtD
Flurazepam—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000932	0.005	CcSEcCtD
Flurazepam—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000932	0.005	CcSEcCtD
Flurazepam—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000932	0.005	CcSEcCtD
Flurazepam—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000912	0.00489	CcSEcCtD
Flurazepam—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000904	0.00485	CcSEcCtD
Flurazepam—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000903	0.00485	CcSEcCtD
Flurazepam—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000896	0.00481	CcSEcCtD
Flurazepam—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000895	0.0048	CcSEcCtD
Flurazepam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00089	0.00478	CcSEcCtD
Flurazepam—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00089	0.00477	CcSEcCtD
Flurazepam—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000886	0.00475	CcSEcCtD
Flurazepam—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000879	0.00472	CcSEcCtD
Flurazepam—Tension—Formoterol—chronic obstructive pulmonary disease	0.000867	0.00465	CcSEcCtD
Flurazepam—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000867	0.00465	CcSEcCtD
Flurazepam—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000866	0.00464	CcSEcCtD
Flurazepam—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000866	0.00464	CcSEcCtD
Flurazepam—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000858	0.0046	CcSEcCtD
Flurazepam—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000858	0.0046	CcSEcCtD
Flurazepam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000844	0.00453	CcSEcCtD
Flurazepam—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000834	0.00447	CcSEcCtD
Flurazepam—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000824	0.00442	CcSEcCtD
Flurazepam—Chloroquine—CYP1A1—chronic obstructive pulmonary disease	0.000824	0.125	CrCbGaD
Flurazepam—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000821	0.0044	CcSEcCtD
Flurazepam—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000819	0.00439	CcSEcCtD
Flurazepam—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000817	0.00438	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000814	0.00437	CcSEcCtD
Flurazepam—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000812	0.00436	CcSEcCtD
Flurazepam—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000812	0.00436	CcSEcCtD
Flurazepam—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000811	0.00435	CcSEcCtD
Flurazepam—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000796	0.00427	CcSEcCtD
Flurazepam—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000787	0.00422	CcSEcCtD
Flurazepam—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000781	0.00419	CcSEcCtD
Flurazepam—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000781	0.00419	CcSEcCtD
Flurazepam—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000775	0.00416	CcSEcCtD
Flurazepam—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000767	0.00411	CcSEcCtD
Flurazepam—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000765	0.0041	CcSEcCtD
Flurazepam—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000764	0.0041	CcSEcCtD
Flurazepam—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000752	0.00404	CcSEcCtD
Flurazepam—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000752	0.00404	CcSEcCtD
Flurazepam—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000752	0.00404	CcSEcCtD
Flurazepam—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000752	0.00404	CcSEcCtD
Flurazepam—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00075	0.00402	CcSEcCtD
Flurazepam—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00075	0.00402	CcSEcCtD
Flurazepam—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000748	0.00401	CcSEcCtD
Flurazepam—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000738	0.00396	CcSEcCtD
Flurazepam—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000737	0.00395	CcSEcCtD
Flurazepam—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000736	0.00395	CcSEcCtD
Flurazepam—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000736	0.00395	CcSEcCtD
Flurazepam—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000734	0.00394	CcSEcCtD
Flurazepam—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000734	0.00393	CcSEcCtD
Flurazepam—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000731	0.00392	CcSEcCtD
Flurazepam—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000721	0.00387	CcSEcCtD
Flurazepam—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000721	0.00387	CcSEcCtD
Flurazepam—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000711	0.00381	CcSEcCtD
Flurazepam—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000711	0.00381	CcSEcCtD
Flurazepam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000708	0.0038	CcSEcCtD
Flurazepam—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000707	0.00379	CcSEcCtD
Flurazepam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000695	0.00373	CcSEcCtD
Flurazepam—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000694	0.00372	CcSEcCtD
Flurazepam—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000684	0.00367	CcSEcCtD
Flurazepam—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00365	CcSEcCtD
Flurazepam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000674	0.00362	CcSEcCtD
Flurazepam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.00362	CcSEcCtD
Flurazepam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000671	0.0036	CcSEcCtD
Flurazepam—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00067	0.00359	CcSEcCtD
Flurazepam—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000658	0.00353	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000657	0.00353	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000657	0.00353	CcSEcCtD
Flurazepam—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000649	0.00348	CcSEcCtD
Flurazepam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000648	0.00348	CcSEcCtD
Flurazepam—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.000648	0.0982	CrCbGaD
Flurazepam—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000644	0.00345	CcSEcCtD
Flurazepam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000643	0.00345	CcSEcCtD
Flurazepam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000643	0.00345	CcSEcCtD
Flurazepam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000641	0.00344	CcSEcCtD
Flurazepam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000641	0.00344	CcSEcCtD
Flurazepam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000636	0.00341	CcSEcCtD
Flurazepam—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000635	0.00341	CcSEcCtD
Flurazepam—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000635	0.00341	CcSEcCtD
Flurazepam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000632	0.00339	CcSEcCtD
Flurazepam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000628	0.00337	CcSEcCtD
Flurazepam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000627	0.00336	CcSEcCtD
Flurazepam—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000622	0.00334	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000621	0.00333	CcSEcCtD
Flurazepam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.00331	CcSEcCtD
Flurazepam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000617	0.00331	CcSEcCtD
Flurazepam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000607	0.00326	CcSEcCtD
Flurazepam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000606	0.00325	CcSEcCtD
Flurazepam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000603	0.00323	CcSEcCtD
Flurazepam—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.0006	0.00322	CcSEcCtD
Flurazepam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000598	0.00321	CcSEcCtD
Flurazepam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000597	0.0032	CcSEcCtD
Flurazepam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000594	0.00319	CcSEcCtD
Flurazepam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000594	0.00319	CcSEcCtD
Flurazepam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000594	0.00318	CcSEcCtD
Flurazepam—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000592	0.00318	CcSEcCtD
Flurazepam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000591	0.00317	CcSEcCtD
Flurazepam—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00316	CcSEcCtD
Flurazepam—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00316	CcSEcCtD
Flurazepam—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000589	0.00316	CcSEcCtD
Flurazepam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.00312	CcSEcCtD
Flurazepam—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000578	0.0031	CcSEcCtD
Flurazepam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000568	0.00305	CcSEcCtD
Flurazepam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000564	0.00302	CcSEcCtD
Flurazepam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000563	0.00302	CcSEcCtD
Flurazepam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000563	0.00302	CcSEcCtD
Flurazepam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000561	0.00301	CcSEcCtD
Flurazepam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00056	0.003	CcSEcCtD
Flurazepam—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00299	CcSEcCtD
Flurazepam—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000551	0.00296	CcSEcCtD
Flurazepam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000531	0.00285	CcSEcCtD
Flurazepam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00278	CcSEcCtD
Flurazepam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00278	CcSEcCtD
Flurazepam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00274	CcSEcCtD
Flurazepam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00274	CcSEcCtD
Flurazepam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00272	CcSEcCtD
Flurazepam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00268	CcSEcCtD
Flurazepam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000494	0.00265	CcSEcCtD
Flurazepam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000494	0.00265	CcSEcCtD
Flurazepam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00262	CcSEcCtD
Flurazepam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000483	0.00259	CcSEcCtD
Flurazepam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00258	CcSEcCtD
Flurazepam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00256	CcSEcCtD
Flurazepam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00256	CcSEcCtD
Flurazepam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00251	CcSEcCtD
Flurazepam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000466	0.0025	CcSEcCtD
Flurazepam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000459	0.00246	CcSEcCtD
Flurazepam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000459	0.00246	CcSEcCtD
Flurazepam—Rash—Formoterol—chronic obstructive pulmonary disease	0.000455	0.00244	CcSEcCtD
Flurazepam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000455	0.00244	CcSEcCtD
Flurazepam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00244	CcSEcCtD
Flurazepam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00244	CcSEcCtD
Flurazepam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00242	CcSEcCtD
Flurazepam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00242	CcSEcCtD
Flurazepam—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000451	0.00242	CcSEcCtD
Flurazepam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00242	CcSEcCtD
Flurazepam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000449	0.00241	CcSEcCtD
Flurazepam—Rash—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00239	CcSEcCtD
Flurazepam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00239	CcSEcCtD
Flurazepam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00237	CcSEcCtD
Flurazepam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.00232	CcSEcCtD
Flurazepam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.0023	CcSEcCtD
Flurazepam—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000429	0.0023	CcSEcCtD
Flurazepam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.0023	CcSEcCtD
Flurazepam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000428	0.0023	CcSEcCtD
Flurazepam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.0023	CcSEcCtD
Flurazepam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00229	CcSEcCtD
Flurazepam—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.00226	CcSEcCtD
Flurazepam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00042	0.00225	CcSEcCtD
Flurazepam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.00217	CcSEcCtD
Flurazepam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000398	0.00213	CcSEcCtD
Flurazepam—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000391	0.0021	CcSEcCtD
Flurazepam—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000384	0.00206	CcSEcCtD
Flurazepam—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000378	0.00203	CcSEcCtD
Flurazepam—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000371	0.00199	CcSEcCtD
Flurazepam—Flunitrazepam—CYP1A2—chronic obstructive pulmonary disease	0.000366	0.0555	CrCbGaD
Flurazepam—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.000347	0.0526	CrCbGaD
Flurazepam—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000328	0.00176	CcSEcCtD
Flurazepam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.00173	CcSEcCtD
Flurazepam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00032	0.00171	CcSEcCtD
Flurazepam—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.000316	0.0479	CrCbGaD
Flurazepam—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000312	0.00167	CcSEcCtD
Flurazepam—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000306	0.00164	CcSEcCtD
Flurazepam—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000296	0.00159	CcSEcCtD
Flurazepam—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000295	0.00158	CcSEcCtD
Flurazepam—GABRR2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000293	0.00304	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000293	0.00304	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000291	0.00302	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00029	0.00301	CbGpPWpGaD
Flurazepam—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000289	0.003	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000288	0.00299	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000286	0.00297	CbGpPWpGaD
Flurazepam—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00152	CcSEcCtD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000282	0.00292	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000282	0.00292	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000281	0.00292	CbGpPWpGaD
Flurazepam—Shock—Prednisone—chronic obstructive pulmonary disease	0.000279	0.0015	CcSEcCtD
Flurazepam—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000277	0.00288	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000276	0.00286	CbGpPWpGaD
Flurazepam—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000274	0.00147	CcSEcCtD
Flurazepam—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000274	0.00284	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000272	0.00283	CbGpPWpGaD
Flurazepam—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00145	CcSEcCtD
Flurazepam—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000267	0.00277	CbGpPWpGaD
Flurazepam—Clomipramine—HTR2A—chronic obstructive pulmonary disease	0.000267	0.0405	CrCbGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000266	0.00276	CbGpPWpGaD
Flurazepam—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	0.000266	0.0403	CrCbGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000265	0.00275	CbGpPWpGaD
Flurazepam—Clonazepam—ALB—chronic obstructive pulmonary disease	0.000263	0.0399	CrCbGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000261	0.00271	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00026	0.0027	CbGpPWpGaD
Flurazepam—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00139	CcSEcCtD
Flurazepam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00139	CcSEcCtD
Flurazepam—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000257	0.00267	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000257	0.00267	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000255	0.00265	CbGpPWpGaD
Flurazepam—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000255	0.00264	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000254	0.00264	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000253	0.00262	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000251	0.0026	CbGpPWpGaD
Flurazepam—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00134	CcSEcCtD
Flurazepam—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000249	0.00258	CbGpPWpGaD
Flurazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000248	0.00258	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000248	0.00258	CbGpPWpGaD
Flurazepam—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00132	CcSEcCtD
Flurazepam—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000247	0.00256	CbGpPWpGaD
Flurazepam—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.00132	CcSEcCtD
Flurazepam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.00132	CcSEcCtD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000246	0.00255	CbGpPWpGaD
Flurazepam—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000245	0.00254	CbGpPWpGaD
Flurazepam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.00131	CcSEcCtD
Flurazepam—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000243	0.0013	CcSEcCtD
Flurazepam—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000242	0.00251	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000242	0.00251	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000241	0.0025	CbGpPWpGaD
Flurazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000241	0.0025	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000238	0.00248	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000237	0.00246	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000237	0.00246	CbGpPWpGaD
Flurazepam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00125	CcSEcCtD
Flurazepam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.000234	0.0354	CrCbGaD
Flurazepam—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000233	0.00242	CbGpPWpGaD
Flurazepam—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00125	CcSEcCtD
Flurazepam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.00124	CcSEcCtD
Flurazepam—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000232	0.00241	CbGpPWpGaD
Flurazepam—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000231	0.0024	CbGpPWpGaD
Flurazepam—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000228	0.00237	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000228	0.00236	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000226	0.00234	CbGpPWpGaD
Flurazepam—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000225	0.00234	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000225	0.00233	CbGpPWpGaD
Flurazepam—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000223	0.00232	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000222	0.0023	CbGpPWpGaD
Flurazepam—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000219	0.00228	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000219	0.00227	CbGpPWpGaD
Flurazepam—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.0329	CrCbGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000213	0.00221	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000212	0.0022	CbGpPWpGaD
Flurazepam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00109	CcSEcCtD
Flurazepam—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000203	0.00211	CbGpPWpGaD
Flurazepam—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000202	0.00209	CbGpPWpGaD
Flurazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000201	0.00209	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000201	0.00209	CbGpPWpGaD
Flurazepam—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00108	CcSEcCtD
Flurazepam—CYP2A6—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000201	0.00208	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000199	0.00207	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000197	0.00205	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000194	0.00202	CbGpPWpGaD
Flurazepam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00104	CcSEcCtD
Flurazepam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000194	0.00201	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000194	0.00201	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000192	0.00199	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00019	0.00197	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000189	0.00196	CbGpPWpGaD
Flurazepam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00101	CcSEcCtD
Flurazepam—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000186	0.00193	CbGpPWpGaD
Flurazepam—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00192	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000184	0.00191	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000184	0.0019	CbGpPWpGaD
Flurazepam—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	0.000183	0.0277	CrCbGaD
Flurazepam—SLC22A2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000183	0.0019	CbGpPWpGaD
Flurazepam—Clomipramine—ALB—chronic obstructive pulmonary disease	0.000183	0.0277	CrCbGaD
Flurazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000182	0.00188	CbGpPWpGaD
Flurazepam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000968	CcSEcCtD
Flurazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00018	0.00187	CbGpPWpGaD
Flurazepam—Rash—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00096	CcSEcCtD
Flurazepam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000959	CcSEcCtD
Flurazepam—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.00185	CbGpPWpGaD
Flurazepam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000954	CcSEcCtD
Flurazepam—CYP2A6—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000174	0.00181	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000171	0.00177	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000169	0.00176	CbGpPWpGaD
Flurazepam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000904	CcSEcCtD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000168	0.00174	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000163	0.00169	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000162	0.00168	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000161	0.00167	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000149	0.00155	CbGpPWpGaD
Flurazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000146	0.00152	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000143	0.00148	CbGpPWpGaD
Flurazepam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.00148	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.0014	CbGpPWpGaD
Flurazepam—Diazepam—ALB—chronic obstructive pulmonary disease	0.000135	0.0204	CrCbGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000134	0.00139	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000133	0.00138	CbGpPWpGaD
Flurazepam—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.00013	0.00135	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000129	0.00134	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000129	0.00134	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000127	0.00132	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000127	0.00132	CbGpPWpGaD
Flurazepam—Chlorpromazine—ALB—chronic obstructive pulmonary disease	0.000125	0.019	CrCbGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000123	0.00128	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000118	0.00123	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000118	0.00122	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000118	0.00122	CbGpPWpGaD
Flurazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.0012	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000115	0.00119	CbGpPWpGaD
Flurazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00118	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000113	0.00117	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00011	0.00114	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000109	0.00113	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.00111	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.00109	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000104	0.00108	CbGpPWpGaD
Flurazepam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00107	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000102	0.00106	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.83e-05	0.00102	CbGpPWpGaD
Flurazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.34e-05	0.00097	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.12e-05	0.000947	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.92e-05	0.000926	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.8e-05	0.000913	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.7e-05	0.000903	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.7e-05	0.000903	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—APIP—chronic obstructive pulmonary disease	8.62e-05	0.000894	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	8.58e-05	0.00089	CbGpPWpGaD
Flurazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.37e-05	0.000869	CbGpPWpGaD
Flurazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.26e-05	0.000858	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.2e-05	0.000851	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.08e-05	0.000839	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	7.91e-05	0.000821	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.77e-05	0.000807	CbGpPWpGaD
Flurazepam—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.66e-05	0.000795	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	7.28e-05	0.000755	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.17e-05	0.000744	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.06e-05	0.000733	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	6.98e-05	0.000724	CbGpPWpGaD
Flurazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.79e-05	0.000704	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.68e-05	0.000693	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.6e-05	0.000685	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	6.29e-05	0.000653	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	6.25e-05	0.000649	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	6.03e-05	0.000626	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.03e-05	0.000626	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.97e-05	0.00062	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.91e-05	0.000613	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.9e-05	0.000613	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.9e-05	0.000612	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.86e-05	0.000608	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.75e-05	0.000597	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.71e-05	0.000592	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.66e-05	0.000587	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.62e-05	0.000583	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	5.55e-05	0.000576	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.52e-05	0.000573	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.48e-05	0.000569	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.24e-05	0.000544	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.23e-05	0.000543	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.23e-05	0.000542	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.23e-05	0.000542	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.16e-05	0.000536	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	5.11e-05	0.00053	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	5.1e-05	0.000529	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.06e-05	0.000526	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.96e-05	0.000515	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.89e-05	0.000508	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.82e-05	0.000501	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.82e-05	0.0005	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.74e-05	0.000492	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.71e-05	0.000489	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.69e-05	0.000487	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.43e-05	0.00046	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	4.38e-05	0.000454	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.3e-05	0.000447	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.24e-05	0.00044	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.14e-05	0.00043	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.14e-05	0.00043	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.09e-05	0.000424	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.08e-05	0.000424	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	4.03e-05	0.000418	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.01e-05	0.000416	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.96e-05	0.000411	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.8e-05	0.000395	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.75e-05	0.000389	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.75e-05	0.000389	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.62e-05	0.000376	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.61e-05	0.000374	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.56e-05	0.000369	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.52e-05	0.000365	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.46e-05	0.000359	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.4e-05	0.000352	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.37e-05	0.00035	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.31e-05	0.000344	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.12e-05	0.000324	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.03e-05	0.000315	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.03e-05	0.000315	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3e-05	0.000311	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.9e-05	0.000301	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.9e-05	0.000301	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.82e-05	0.000293	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.78e-05	0.000289	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.75e-05	0.000286	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.74e-05	0.000284	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.66e-05	0.000276	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.52e-05	0.000262	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.52e-05	0.000262	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.51e-05	0.000261	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.42e-05	0.000251	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.31e-05	0.00024	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.31e-05	0.00024	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.27e-05	0.000235	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.2e-05	0.000228	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.18e-05	0.000226	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.16e-05	0.000224	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.1e-05	0.000218	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.07e-05	0.000215	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.99e-05	0.000206	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.93e-05	0.000201	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.93e-05	0.0002	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.92e-05	0.000199	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.9e-05	0.000198	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.9e-05	0.000198	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.87e-05	0.000194	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.83e-05	0.00019	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.83e-05	0.00019	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.77e-05	0.000184	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.74e-05	0.00018	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.68e-05	0.000175	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.66e-05	0.000172	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.64e-05	0.00017	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.53e-05	0.000158	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.5e-05	0.000156	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.49e-05	0.000155	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.45e-05	0.000151	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.4e-05	0.000145	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.000143	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.000138	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.25e-05	0.000129	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.19e-05	0.000124	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.000119	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.14e-05	0.000119	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.13e-05	0.000118	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.09e-05	0.000113	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.00011	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.02e-05	0.000106	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.01e-05	0.000105	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.000104	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.21e-06	9.56e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	9.03e-06	9.38e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.64e-06	8.97e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.49e-06	8.81e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.08e-06	7.35e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.98e-06	7.24e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	6.8e-06	7.06e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.51e-06	6.75e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.5e-06	6.75e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.17e-06	6.4e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.19e-06	4.35e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.01e-06	4.16e-05	CbGpPWpGaD
